(Q72664928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

1 reference

M E Thomas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

K P Harris

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

C Ramaswamy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J M Hattersley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

D C Wheeler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Z Varghese

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J D Williams

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J Walls

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

J F Moorhead

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

language of work or name

English

0 references

publication date

1 November 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

1124-1129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1993.358

28 October 2019

exact match

0 references

cites work

The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Low-density lipoprotein metabolism in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Clinical implications of new drugs for lowering plasma cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Lipoprotein(a) in patients with proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

The Nephrotic Syndrome and Ischaemic Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Cardiovascular Disease and the Nephrotic Syndrome: the other Side of the Coin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Cholesterol and total mortality: need for larger trials

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Focal and segmental glomerulosclerosis: analogies to atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Efficacy and long-term adverse effect pattern of lovastatin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

The effects of lovastatin in hyperlipidemic patients with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Lovastatin in glomerulonephritis patients with hyperlipidaemia and heavy proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Proteinuria as complication of simvastatin treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Simvastatin and proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Partial remission of nephrotic syndrome in patient on long-term simvastatin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.358

7 January 2021

Identifiers

DOI

10.1038/KI.1993.358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8264145%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference